| PIK3CA (p110a) | PIK | Atypical | 8twy | A | | 1-(4-{[2-(4-{(4p)-4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-[(3s)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethoxy]methyl}piperidin-1-yl)prop-2-en-1-one | Human | 15392 | |
| PIK3CA (p110a) | PIK | Atypical | 8exo | A | B | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14534 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | A | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14537 | |
| PIK3CA (p110a) | PIK | Atypical | 8exo | A | A | 1-{(4s,11am)-2-[(4r)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-prolinamide | Human | 14541 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14542 | |
| PIK3CA (p110a) | PIK | Atypical | 8gud | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14535 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14348 | |
| PIK3CA (p110a) | PIK | Atypical | 7mlk | A | A | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | 14216 | |
| PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | A | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | 14223 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsd | A | | - | Human | 15090 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8h | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15249 | |
| PIK3CA (p110a) | PIK | Atypical | 7myn | A | B | - | Human | 13964 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8i | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15248 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8u | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 15250 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8v | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 15252 | |
| PIK3CA (p110a) | PIK | Atypical | 8v8j | A | | (2s)-n~1~-[(4p)-2-tert-butyl-4'-methyl[4,5'-bi-1,3-thiazol]-2'-yl]pyrrolidine-1,2-dicarboxamide | Human | 15251 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovu | A | B | - | Human | 9271 | |
| PIK3CA (p110a) | PIK | Atypical | 6pys | A | B | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11576 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovv | A | | - | Human | 9307 | |
| PIK3CA (p110a) | PIK | Atypical | 7mlk | A | B | 4-[6-(3,4,5-trimethoxyanilino)pyrazin-2-yl]benzamide | Human | 14217 | |
| PIK3CA (p110a) | PIK | Atypical | 4ovu | A | A | - | Human | 9291 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxb | A | | - | Human | 9282 | |
| PIK3CA (p110a) | PIK | Atypical | 5swo | A | | - | Human | 9303 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14970 | |
| PIK3CA (p110a) | PIK | Atypical | 8tu6 | A | | - | Human | 14971 | |
| PIK3CA (p110a) | PIK | Atypical | 8ils | A | B | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14968 | |
| PIK3CA (p110a) | PIK | Atypical | 8ilv | A | | n-[(2r)-1-(ethylamino)-1-oxidanylidene-3-[3-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14974 | |
| PIK3CA (p110a) | PIK | Atypical | 8w9b | A | | - | Human | 15273 | |
| PIK3CA (p110a) | PIK | Atypical | 8w9a | A | | - | Human | 15274 | |
| PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | B | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | 9309 | |
| PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | A | - | Human | 14765 | |
| Pik3ca (p110a) | PIK | Atypical | 4a55 | A | | pik-108 | Mouse | 9403 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsc | A | | - | Human | 15084 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsb | A | | - | Human | 15085 | |
| PIK3CA (p110a) | PIK | Atypical | 8tsa | A | | - | Human | 15087 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts7 | A | | - | Human | 15088 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts9 | A | | - | Human | 15089 | |
| PIK3CA (p110a) | PIK | Atypical | 7myo | B | A | - | Human | 13962 | |
| PIK3CA (p110a) | PIK | Atypical | 5fi4 | A | A | ~{n}-[6-[5-azanyl-6-[(2~{s})-1,1,1-tris(fluoranyl)propan-2-yl]oxy-pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]ethanamide | Human | 9302 | |
| PIK3CA (p110a) | PIK | Atypical | 6oac | A | | 4-(difluoromethyl)-5-{4-[(3s)-3-methylmorpholin-4-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}pyridin-2-amine | Human | 11381 | |
| PIK3CA (p110a) | PIK | Atypical | 4tuu | A | | - | Human | 9281 | |
| PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | B | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | 9308 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxf | A | | - | Human | 9284 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14969 | |
| PIK3CA (p110a) | PIK | Atypical | 8ts8 | A | | - | Human | 15086 | |
| PIK3CA (p110a) | PIK | Atypical | 7jiu | A | B | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | 13761 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxe | A | | - | Human | 9280 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgh | A | | 3-[(4-fluorophenyl)methylamino]-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | 9864 | |
| PIK3CA (p110a) | PIK | Atypical | 4waf | A | A | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9288 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxk | A | | - | Human | 9296 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6m | A | B | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | 13227 | |
| PIK3CA (p110a) | PIK | Atypical | 7r9y | A | | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-n-methyl-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | 14179 | |
| PIK3CA (p110a) | PIK | Atypical | 3hhm | A | | (1s,6br,9as,11r,11br)-9a,11b-dimethyl-1-[(methyloxy)methyl]-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3h-furo[4,3,2-de]indeno[4,5-h][2]benzopyran-11-yl acetate | Human | 9275 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxj | A | | - | Human | 9301 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxt | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 9299 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw5 | A | B | - | Human | 16019 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgj | A | | 3-(4-morpholin-4-ylfuro[3,2-d]pyrimidin-2-yl)-5-[(phenylmethyl)amino]phenol | Human | 9863 | |
| PIK3CA (p110a) | PIK | Atypical | 8ow2 | A | B | - | Human | 14764 | |
| PIK3CA (p110a) | PIK | Atypical | 9b4s | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 16024 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcp | A | A | - | Human | 14380 | |
| PIK3CA (p110a) | PIK | Atypical | 5swt | A | | - | Human | 9273 | |
| PIK3CA (p110a) | PIK | Atypical | 4zop | A | A | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | 9298 | |
| PIK3CA (p110a) | PIK | Atypical | 5xgi | A | | 3-azanyl-5-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol | Human | 9865 | |
| PIK3CA (p110a) | PIK | Atypical | 5swp | A | | - | Human | 9293 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxd | A | | - | Human | 9304 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw7 | A | B | - | Human | 16025 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxh | A | | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | 9310 | |
| PIK3CA (p110a) | PIK | Atypical | 4zop | A | B | (2s,3r)-n~1~-(8-tert-butyl-4,5-dihydro[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide | Human | 9312 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbc | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | 14842 | |
| PIK3CA (p110a) | PIK | Atypical | 7myo | B | B | - | Human | 13965 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg6 | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14349 | |
| PIK3CA (p110a) | PIK | Atypical | 4ykn | A | A | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | 9283 | |
| PIK3CA (p110a) | PIK | Atypical | 6nct | A | | - | Human | 11221 | |
| PIK3CA (p110a) | PIK | Atypical | 8ilr | A | B | n-[(2s)-1-(ethylamino)-1-oxidanylidene-3-[4-(2-quinoxalin-6-ylethynyl)phenyl]propan-2-yl]-2,3-dimethyl-quinoxaline-6-carboxamide | Human | 14973 | |
| PIK3CA (p110a) | PIK | Atypical | 9nid | A | | - | Human | 16026 | |
| PIK3CA (p110a) | PIK | Atypical | 9nlc | A | | - | Human | 16027 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw8 | A | A | - | Human | 16028 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw5 | A | A | - | Human | 16029 | |
| PIK3CA (p110a) | PIK | Atypical | 9lws | A | | - | Human | 16011 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvi | A | A | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | 11656 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni8 | A | | - | Human | 16007 | |
| PIK3CA (p110a) | PIK | Atypical | 5itd | A | | 5-{4-[3-(4-acetylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl}-2-methoxypyridine-3-carbonitrile | Human | 9313 | |
| PIK3CA (p110a) | PIK | Atypical | 8tdu | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14967 | |
| PIK3CA (p110a) | PIK | Atypical | 5sx9 | A | | - | Human | 9305 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbj | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | 14839 | |
| PIK3CA (p110a) | PIK | Atypical | 9cmv | A | | - | Human | 16008 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvi | A | B | 3-(2-azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine | Human | 11654 | |
| PIK3CA (p110a) | PIK | Atypical | 4l1b | A | | - | Human | 9292 | |
| PIK3CA (p110a) | PIK | Atypical | 8bfu | A | | - | Human | 14613 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd8 | A | | - | Human | 14375 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwr | A | A | - | Human | 16009 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6n | A | B | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | 13224 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvf | A | B | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11658 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvf | A | A | 5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11659 | |
| PIK3CA (p110a) | PIK | Atypical | 7myn | A | A | - | Human | 13963 | |
| PIK3CA (p110a) | PIK | Atypical | 8am0 | A | | (2r)-2-[[2-[(4s)-4-[bis(fluoranyl)methyl]-2-oxidanylidene-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide | Human | 15083 | |
| PIK3CA (p110a) | PIK | Atypical | 5swg | A | | - | Human | 9306 | |
| PIK3CA (p110a) | PIK | Atypical | 7r9v | A | | n-[2-(4-{4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethyl]-1-(prop-2-enoyl)piperidine-4-carboxamide | Human | 14178 | |
| PIK3CA (p110a) | PIK | Atypical | 5swr | A | | - | Human | 9279 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni7 | A | | - | Human | 16010 | |
| PIK3CA (p110a) | PIK | Atypical | 7k71 | A | | 2-(morpholin-4-yl)[4,5'-bipyrimidin]-2'-amine | Human | 13219 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | A | - | Human | 14346 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcp | A | B | - | Human | 14376 | |
| PIK3CA (p110a) | PIK | Atypical | 5ul1 | A | A | 3-amino-6-(4-{[(2s)-1-(dimethylamino)propan-2-yl]sulfonyl}phenyl)-n-phenylpyrazine-2-carboxamide | Human | 9316 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6o | A | B | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | 13206 | |
| PIK3CA (p110a) | PIK | Atypical | 7pg5 | A | B | - | Human | 14347 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbj | A | B | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(1h-pyrazol-3-yl)-3h-imidazo[4,5-b]pyridine | Human | 14840 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxa | A | | - | Human | 9285 | |
| PIK3CA (p110a) | PIK | Atypical | 9b4t | A | | (2s)-2-({2-[1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | Human | 16012 | |
| PIK3CA (p110a) | PIK | Atypical | 7jiu | A | A | (3s)-3-benzyl-5-[9-ethyl-8-(2-methylpyrimidin-5-yl)-9h-purin-6-yl]-3-methyl-1,3-dihydro-2h-indol-2-one | Human | 13760 | |
| PIK3CA (p110a) | PIK | Atypical | 4waf | A | B | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9272 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvh | A | A | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11657 | |
| PIK3CA (p110a) | PIK | Atypical | 8exl | A | B | 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide | Human | 14536 | |
| PIK3CA (p110a) | PIK | Atypical | 5ubr | A | | 1-[4-(3-{4-amino-5-[1-(oxan-4-yl)-1h-pyrazol-5-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl}phenyl)piperazin-1-yl]ethan-1-one | Human | 9289 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6m | A | A | 2,2-difluoroethyl (3s)-3-{[2'-amino-5-fluoro-2-(morpholin-4-yl)[4,5'-bipyrimidin]-6-yl]amino}-3-(hydroxymethyl)pyrrolidine-1-carboxylate | Human | 13225 | |
| PIK3CA (p110a) | PIK | Atypical | 4jps | A | A | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 9317 | |
| PIK3CA (p110a) | PIK | Atypical | 8dcx | A | | - | Human | 14377 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni5 | A | | - | Human | 16013 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw7 | A | A | - | Human | 16014 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6n | A | A | tert-butyl (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate | Human | 13226 | |
| PIK3CA (p110a) | PIK | Atypical | 3zim | A | | 1-[4-[[2-(1h-indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-6-methyl-hept-5-ene-1,4-dione | Human | 9294 | |
| PIK3CA (p110a) | PIK | Atypical | 5sw8 | A | | - | Human | 9274 | |
| PIK3CA (p110a) | PIK | Atypical | 4tv3 | A | | 2-amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8h)-one | Human | 9278 | |
| PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | A | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | 9295 | |
| PIK3CA (p110a) | PIK | Atypical | 5ukj | A | | n,n-dimethyl-4-[(6r)-6-methyl-5-(1h-pyrrolo[2,3-b]pyridin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide | Human | 9277 | |
| PIK3CA (p110a) | PIK | Atypical | 7k6o | A | A | (3s)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7h-pyrrolo[2,3-d]pyrimidin-7-yl]-n-methylpyrrolidine-1-sulfonamide | Human | 13207 | |
| PIK3CA (p110a) | PIK | Atypical | 2rd0 | A | | - | Human | 9287 | |
| PIK3CA (p110a) | PIK | Atypical | 4l23 | A | | 3-(4-morpholin-4-ylpyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl)phenol | Human | 9290 | |
| PIK3CA (p110a) | PIK | Atypical | 6pys | A | A | (3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one | Human | 11575 | |
| PIK3CA (p110a) | PIK | Atypical | 4l2y | A | | 3-amino-5-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol | Human | 9276 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvg | A | | 5-(6-azanyl-4-methyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11655 | |
| PIK3CA (p110a) | PIK | Atypical | 7tz7 | A | B | (4s,5r)-3-[2'-amino-2-(morpholin-4-yl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one | Human | 14222 | |
| PIK3CA (p110a) | PIK | Atypical | 3hiz | A | | - | Human | 9311 | |
| PIK3CA (p110a) | PIK | Atypical | 9nie | A | | - | Human | 16015 | |
| PIK3CA (p110a) | PIK | Atypical | 4jps | A | B | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 9314 | |
| PIK3CA (p110a) | PIK | Atypical | 8exv | A | B | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14538 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwq | A | | - | Human | 16016 | |
| PIK3CA (p110a) | PIK | Atypical | 9yf2 | A | | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 16017 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni3 | A | | - | Human | 16018 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxi | A | | - | Human | 9270 | |
| PIK3CA (p110a) | PIK | Atypical | 4ykn | A | B | 3-(6-methoxypyridin-3-yl)-5-[({4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}amino)methyl]benzoic acid | Human | 9315 | |
| PIK3CA (p110a) | PIK | Atypical | 8exu | A | A | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | 14539 | |
| PIK3CA (p110a) | PIK | Atypical | 8gua | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14540 | |
| PIK3CA (p110a) | PIK | Atypical | 9lwr | A | B | - | Human | 16020 | |
| PIK3CA (p110a) | PIK | Atypical | 5dxh | D | | methyl {2-[4-(2-chlorophenyl)-4h-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepin-8-yl}carbamate | Human | 9300 | |
| PIK3CA (p110a) | PIK | Atypical | 5sx8 | A | | - | Human | 9269 | |
| PIK3CA (p110a) | PIK | Atypical | 8sbc | A | A | (2m)-7-[(3r)-3-methylmorpholin-4-yl]-5-[(3s)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1h-imidazo[4,5-b]pyridine | Human | 14841 | |
| PIK3CA (p110a) | PIK | Atypical | 9nif | A | | - | Human | 16021 | |
| PIK3CA (p110a) | PIK | Atypical | 8tgd | A | A | n~2~-{(4s,11ap)-2-[(4s)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-l-alaninamide | Human | 14972 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | A | - | Human | 14378 | |
| PIK3CA (p110a) | PIK | Atypical | 9c15 | A | | - | Human | 16022 | |
| PIK3CA (p110a) | PIK | Atypical | 8dd4 | A | B | - | Human | 14379 | |
| PIK3CA (p110a) | PIK | Atypical | 9xw8 | A | B | - | Human | 16023 | |
| PIK3CA (p110a) | PIK | Atypical | 6gvh | A | B | 5-(6-azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Human | 11653 | |
| PIK3CA (p110a) | PIK | Atypical | 5sxc | A | | - | Human | 9297 | |
| PIK3CA (p110a) | PIK | Atypical | 9ni4 | A | | - | Human | 16030 | |
| PIK3CA (p110a) | PIK | Atypical | 8gub | A | | (2s)-n~1~-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide | Human | 14543 | |
| PIK3CA (p110a) | PIK | Atypical | 8exu | A | B | (2s)-2-cyclopropyl-2-({(4s,11am)-2-[(4s)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide | Human | 14544 | |
| PIK3CA (p110a) | PIK | Atypical | 5uk8 | A | B | (r)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1h-indol-4-yl)pyrimidin-4-yl)-3-methylmorpholine | Human | 9286 | |